Theodore Alkousakis, MD
Dermatology · Aurora, CONPI 1992830269
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $24,250 of the $34,239 with a category attached, or 70.8%. Novartis accounts for 97.0% of it on its own, with 17 other manufacturers making up the rest. Reporting peaked in 2019 at $21,731 and has fallen 99.7% since, to $67 in 2025. Among dermatology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 80 payments — averaging $427.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$33K
- Lilly USA, LLC$272
- AbbVie$245
- Pfizer$99
- Janssen Scientific Affairs, LLC$53
- Dermira, Inc.$49
- plus $322 from 12 others
Across 224 payments — averaging $3778.49 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$499K
- AbbVie$233K
- Kiniksa Pharmaceuticals, Ltd.$91K
- Sun Pharmaceutical Industries Inc.$22K
- Eli Lilly$770
What the payments were for
- Consulting fees$7,50022%
- Speaking & faculty fees$24,25071%
- Travel & lodging$5652%
- Food & beverage$1,9246%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 33 | $33,198 |
| Lilly USA, LLC | 16 | $272 |
| AbbVie | 8 | $245 |
| Pfizer | 1 | $99 |
| Janssen Scientific Affairs, LLC | 4 | $53 |
| Dermira, Inc. | 2 | $49 |
| Amgen | 2 | $46 |
| Genentech USA, Inc. | 2 | $43 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| Sun Pharmaceutical Industries Inc. | 2 | $36 |
| LEO Pharma Inc. | 2 | $30 |
| Johnson & Johnson | 1 | $27 |
| Almirall LLC | 1 | $24 |
| Sanofi | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Aclaris Therapeutics, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,239 in reported general payments places this provider in the 90th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Aurora
- David NorrisAurora$156K
- Dawnielle EndlyAurora$105K
- Torunn SivesindAurora$93K
- Carla Torres-ZegarraAurora$62K
- Cory DunnickAurora$39K
- Emily GorellAurora$27K
- Ryan GambleAurora$10K
- Jennifer RayAurora$9K
- Ryan OlearyAurora$8K
- Marcjonathan SerotaLittleton$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.